Immuneering CorporationIMRXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-56M

+8.2% YoY

Free Cash Flow

$-45M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	2	0↓84.8%	0	0	0
Gross Profit	1	0↓82.9%	0	0	-1
Operating Income	-34	-52↓52.7%	-58↓12.9%	-64↓9.7%	-59↑7.3%
Net Income	-34	-51↓50.6%	-53↓5.9%	-61↓14.1%	-56↑8.2%
EBITDA	-34	-51↓52.6%	-58↓12.8%	-64↓9.7%	-59↑7.9%
EPS Diluted	-1.27	-1.87↓47.2%	-1.88↓0.5%	-2.04↓8.5%	-1.27↑37.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	75	73↓3.0%	59↓18.2%	36↓39.2%	129↑255.9%
Total Current Assets	152	109↓28.6%	89↓18.1%	40↓55.6%	176↑345.2%
Total Assets	167	122↓26.6%	103↓16.2%	53↓48.6%	232↑340.1%
Total Current Liabilities	6	8↑43.0%	8↓2.6%	8↓4.4%	10↑34.2%
Total Liabilities	11	13↑16.7%	12↓4.1%	11↓5.7%	14↑19.2%
Total Equity	156	110↓29.6%	91↓17.5%	41↓54.3%	218↑427.9%
Total Debt	5	5↓9.8%	4↓7.8%	4↓6.7%	4↓8.1%
Net Debt	-70	-68↑2.5%	-55↑19.0%	-32↑41.8%	-125↓290.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-31	-44↓42.9%	-49↓11.0%	-55↓12.3%	-45↑17.6%
Capital Expenditure	-0	-1↓1121.5%	-0↑53.8%	-0↑75.2%	-0↓67.6%
Free Cash Flow	-31	-45↓45.1%	-49↓10.0%	-55↓11.7%	-45↑17.4%
Stock-Based Comp	2	0	6	7↑13.5%	0
Net Change in Cash	38	-2↓106.0%	-13↓487.7%	-23↓75.8%	93↑497.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance